Francomano Robert 4
4 · SELLAS Life Sciences Group, Inc. · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Francomano Robert
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-14+100,000→ 100,000 totalExercise: $5.23Exp: 2032-03-14→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]One-quarter (1/4) of the option shares will vest and became exercisable one year from the March 14, 2022 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter.